Compound ID | 62
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | S. epidermidis, S. haemolyticus, and S. hominis biofilms |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China |
| Year first mentioned: | 2013 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |